A Study on Rheumatoid Arthritis Patients Treated With Rituximab

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to obtain an overall picture of rituximab treatments and treatment responses in RA patients.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hoffmann-La Roche
• Treatments: Rituximab

Criteria

Inclusion Criteria:

• Rheumatoid arthritis (RA) patients treated with rituximab in Finland

Exclusion Criteria:

• Not applicable